1 equent activation of TAFI, thereby appearing
profibrinolytic.
2 glycosaminoglycan, exerts antithrombotic and
profibrinolytic actions with a low bleeding risk when ad
3 ion in APC's anticoagulant and APC-dependent
profibrinolytic activities.
4 Compared with rwt-APC, 5A-APC had minimal
profibrinolytic activity and preserved TAFI-mediated ant
5 ectin functions as a cofactor to promote the
profibrinolytic activity of APC.
6 As an antithrombotic/
profibrinolytic agent, it plays a clear role in maintain
7 PC functions as an anti-coagulant,
profibrinolytic,
and anti-inflammatory agent, and, thus,
8 ms of hemostasis, exhibiting antithrombotic,
profibrinolytic,
and anti-inflammatory properties.
9 ated) has anti-inflammatory, antithrombotic,
profibrinolytic,
and other properties that may explain t
10 Activated protein C (APC) possesses
profibrinolytic,
anti-inflammatory, and anti-apoptotic p
11 d protein C (aPC), possesses antithrombotic,
profibrinolytic,
anti-inflammatory, and antiapoptotic pr
12 Annexin 2 is a
profibrinolytic co-receptor for plasminogen and tissue p
13 A2 (A2) heterotetramer (A2.p11)(2) is a key
profibrinolytic complex that assembles plasminogen and t
14 gainst TAFI and PAI-1 results in a prominent
profibrinolytic effect in mice without increased bleedin
15 Insulin has an anti-inflammatory and
profibrinolytic effect in patients with acute MI.
16 the extent to which TAFI is involved in the
profibrinolytic effect of APC in a plasma-based system.
17 his hypothesis was tested by determining the
profibrinolytic effect of APC on lysis time using clots
18 The
profibrinolytic effect of APC was also compared with tha
19 Therefore, the majority of the
profibrinolytic effect of APC, in an in vitro plasma sys
20 factor VaLeiden specifically attenuates the
profibrinolytic effect of APC.
21 ined by its associated anti-inflammatory and
profibrinolytic effects.
22 Annexin 2 (A2) is a
profibrinolytic endothelial cell surface receptor that b
23 ctly as an anticoagulant and indirectly as a
profibrinolytic enzyme.
24 We also tested release of
profibrinolytic enzymes, urokinase, and tissue plasminog
25 Our data are the first to document a
profibrinolytic function of platelet polyP.
26 C, has antithrombotic, antiinflammatory, and
profibrinolytic properties.
27 ant function, APC is also known to possess a
profibrinolytic property.
28 Thus, an impaired TAFI-dependent
profibrinolytic response to APC in APC-resistant individ